Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J H Porter

Showing results (51-60 of 232) with videos related to

Pageof 24
Sort By:
Advanced Drug Delivery Reviews|December 25, 2007
Enhancing intestinal drug solubilisation using lipid-based delivery systemsChristopher J H Porter, Colin W Pouton, Jean F Cuine, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulationsAnn Marie Kaukonen, Ben J Boyd, Christopher J H Porter, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugsGreg A Kossena, William N Charman, Ben J Boyd, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearanceLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|May 25, 2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studiesSuzanne M Caliph, Natalie L Trevaskis, William N Charman, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipidsAnn Marie Kaukonen, Ben J Boyd, William N Charman, et al.
Journal of Pharmaceutical Sciences|December 25, 2004
Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drugGreg A Kossena, William N Charman, Ben J Boyd, et al.
Pharmaceutical Research|July 17, 2010
The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profilesNatalie L Trevaskis, Ravi M Shanker, William N Charman, et al.
Journal of Medicinal Chemistry|June 7, 2008
Characterization of the drug binding specificity of rat liver fatty acid binding proteinSara Chuang, Tony Velkov, James Horne, et al.
Molecular Pharmaceutics|December 22, 2016
Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption PeriodsMatthew F Crum, Natalie L Trevaskis, Colin W Pouton, et al.
Pageof 24

Showing results (51-60 of 232) with videos related to

Sort By:
Pageof 24
Advanced Drug Delivery Reviews|December 25, 2007
Enhancing intestinal drug solubilisation using lipid-based delivery systemsChristopher J H Porter, Colin W Pouton, Jean F Cuine, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulationsAnn Marie Kaukonen, Ben J Boyd, Christopher J H Porter, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugsGreg A Kossena, William N Charman, Ben J Boyd, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearanceLisa M Kaminskas, Victoria M McLeod, Christopher J H Porter, et al.
Journal of Pharmaceutical Sciences|May 25, 2012
Intravenous dosing conditions may affect systemic clearance for highly lipophilic drugs: implications for lymphatic transport and absolute bioavailability studiesSuzanne M Caliph, Natalie L Trevaskis, William N Charman, et al.
Pharmaceutical Research|March 23, 2004
Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipidsAnn Marie Kaukonen, Ben J Boyd, William N Charman, et al.
Journal of Pharmaceutical Sciences|December 25, 2004
Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drugGreg A Kossena, William N Charman, Ben J Boyd, et al.
Pharmaceutical Research|July 17, 2010
The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profilesNatalie L Trevaskis, Ravi M Shanker, William N Charman, et al.
Journal of Medicinal Chemistry|June 7, 2008
Characterization of the drug binding specificity of rat liver fatty acid binding proteinSara Chuang, Tony Velkov, James Horne, et al.
Molecular Pharmaceutics|December 22, 2016
Transient Supersaturation Supports Drug Absorption from Lipid-Based Formulations for Short Periods of Time, but Ongoing Solubilization Is Required for Longer Absorption PeriodsMatthew F Crum, Natalie L Trevaskis, Colin W Pouton, et al.
Pageof 24